AXGN Q4 2023 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q4 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$43M+18.7% YoY

Gross Profit

$34M78.7% margin

Operating Income

-$3M-7.4% margin

Net Income

-$4M-9.1% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

+4.0%

Cash Flow

Operating Cash Flow

-$211,000

Free Cash Flow

-$2M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$197M

Total Liabilities

$101M

Stockholders' Equity

$96M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$43M	$36M	+18.7%
Gross Profit	$34M	$30M	+12.5%
Operating Income	-$3M	-$6M	+43.0%
Net Income	-$4M	-$5M	+28.1%